NCT03862469View on ClinicalTrials.gov

Premenstrual Hormonal and Affective State Evaluation (PHASE) Project

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

September 26, 2019

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Premenstrual Dysphoric Disorder
Interventions
PROCEDURE

Individualized laboratory test

Laboratory test administered between 6 and 2 days prior to the subsequent menstrual cycle.

Trial Locations (1)

60612

University of Illinois Department of Pharmacy Practice, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT03862469 - Premenstrual Hormonal and Affective State Evaluation (PHASE) Project | Biotech Hunter | Biotech Hunter